FIG. 3.

Log-transformed white matter hyperintensity volume (95% CI) of treatment arms relative to placebo. oCEE, oral conjugated equine estrogens; tE2, transdermal 17β-estradiol; WMH, white matter hyperintensity

Log-transformed white matter hyperintensity volume (95% CI) of treatment arms relative to placebo. oCEE, oral conjugated equine estrogens; tE2, transdermal 17β-estradiol; WMH, white matter hyperintensity